Related by context. Frequent words. (Click for all words.) 68 unresectable locally advanced 67 nonsmall cell lung cancer 67 recurrent glioblastoma multiforme 67 refractory chronic lymphocytic 67 medullary thyroid cancer 66 colorectal lung 66 metastatic colorectal 65 lung pancreatic 64 VEGFR2 inhibitor 64 Gleevec resistant 64 differentiated thyroid 64 forodesine 63 Panzem R NCD 63 R sorafenib tablets 63 non squamous 63 breast pancreatic 63 HER2 positive metastatic breast 63 Vandetanib 62 pancreatic adenocarcinoma 62 TTR amyloidosis 62 Zolinza 62 refractory CLL 62 Initiates Phase II 62 metastatic lung cancer 62 cutaneous T 62 lymphoma leukemia 62 metastatic renal cell carcinoma 62 PD LID 62 rheumatoid arthritis psoriasis 62 Cutaneous T 61 Ixempra 61 metastatic hormone refractory 61 refractory AML 61 recurrent glioblastoma 61 gemcitabine chemotherapy 61 IV melanoma 61 interferon gamma 1b 61 ovarian breast 61 colorectal carcinoma 61 huC# DM4 61 histone deacetylase HDAC inhibitor 61 Acute Myeloid Leukemia AML 61 post herpetic neuralgia PHN 61 metastatic kidney 61 Alemtuzumab 61 diagnosed GBM 61 pamidronate 61 vismodegib 61 rheumatoid arthritis psoriatic arthritis 61 ThermoDox R 61 opioid induced bowel dysfunction 60 Gliadel Wafer 60 advanced carcinoid 60 radiofrequency ablation RFA 60 histologically confirmed 60 Daclizumab 60 adriamycin 60 malignant pleural mesothelioma 60 advanced unresectable 60 multiple myeloma MM 60 Torisel 60 HuMax EGFr 60 Pralatrexate 60 anti angiogenic therapy 60 Allovectin 7 ® 60 heavily pretreated 60 superficial bladder cancer 60 Phase Ib IIa 60 seminoma 60 allogeneic stem cell 60 multiple sclerosis rheumatoid arthritis 60 rheumatoid arthritis lupus 60 Faslodex 60 sunitinib malate 60 vandetanib 60 pertuzumab 60 pemphigus vulgaris 59 gastrointestinal stromal tumors GIST 59 castrate resistant prostate cancer 59 Erlotinib 59 myeloproliferative disorders 59 pancreatic neuroendocrine tumors 59 neovascular age 59 ixabepilone 59 Tarceva erlotinib 59 relapsed refractory multiple myeloma 59 Combination therapy 59 motesanib 59 HNSCC 59 liposomal formulation 59 Darinaparsin 59 refractory multiple myeloma 59 Panzem R 59 Canvaxin 59 Zytiga 59 pheochromocytoma 59 breast carcinoma 59 Diabetic Neuropathy 59 2 methoxyestradiol 59 Proxinium TM 59 gets USFDA nod